{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:07:00Z","timestamp":1770962820045,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"vor","delay-in-days":7637,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1111\/1523-1747.ep12612749","type":"journal-article","created":{"date-parts":[[2004,7,12]],"date-time":"2004-07-12T19:49:16Z","timestamp":1089661756000},"page":"189-193","source":"Crossref","is-referenced-by-count":36,"title":["Levels of Skin-Derived Antileukoproteinase (SKALP)\/Elafin in Serum Correlate with Disease Activity During Treatment of Severe Psoriasis with Cyclosporin A"],"prefix":"10.1016","volume":"104","author":[{"given":"Hans A.C.","family":"Alkemade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gijs J.","family":"De Jongh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Peter","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.M.","family":"van de Kerkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12612749_bb0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1990.tb07285.x","article-title":"Skin-derived antileucoproteinases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis","volume":"122","author":"Schalkwijk","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0015","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","article-title":"Elafin: an elastase specific inhibitor of human skin. Purification characterization and complete amino acid sequence","volume":"265","author":"Wiedow","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/1523-1747.ep12612749_bb0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-291X(05)80981-7","article-title":"Primary structure of the human elafin precursor preproclafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment","volume":"185","author":"Saheki","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/1523-1747.ep12612749_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.1988.tb00658.x","article-title":"Enzymatic quantification of polymorphonuclear leukocytes in normal and psoriatic skin following standardized injury","volume":"13","author":"Chang","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0030","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1242\/jcs.107.8.2335","article-title":"SKALP\/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes","volume":"107","author":"Alkemade","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1111\/1523-1747.ep12612749_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/0001555570147151","article-title":"Elastase-inhibiting activity in scaling skin disorders","volume":"70","author":"Chang","year":"1990","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/1523-1747.ep12612749_bb0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0006-291X(91)90476-N","article-title":"Elafin is a potent inhibitor of proteinase 3","volume":"174","author":"Wiedow","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/1523-1747.ep12612749_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0925-4439(91)90053-C","article-title":"Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties","volume":"1096","author":"Schalkwijk","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/1523-1747.ep12612749_bb0050","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1016\/S0021-9258(19)50303-9","article-title":"SKALP\/Elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence and evidence for transglutaminase crosslinking","volume":"268","author":"Molhuizen","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1111\/1523-1747.ep12612749_bb0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1523-1747.ep12471990","article-title":"Immunohistochemical localization of SKALP\/elafin in psoriatic epidermis","volume":"100","author":"Schalkwijk","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0060","first-page":"1679","article-title":"Differential expression of SKALP\/elafin in human epidermal tumors","volume":"143","author":"Alkemade","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1111\/1523-1747.ep12612749_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000133683","article-title":"Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20ql2-ql3","volume":"66","author":"Molhuizen","year":"1994","journal-title":"Cytogenet Cell Genet"},{"key":"10.1111\/1523-1747.ep12612749_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12611375","article-title":"Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients","volume":"99","author":"Alkemade","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0075","first-page":"422","article-title":"Metabolism and urinary excretion of elafin, a specific inhibitor of human leukocyte elastase (abstr)","volume":"101","author":"Streit","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis-oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/1523-1747.ep12612749_bb0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1165\/ajrcmb\/8.2.126","article-title":"Secretion of mucus proteinase inhibitor and elafin by clara cell and type II pneumocyte cell lines","volume":"8","author":"Sallenave","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/1523-1747.ep12612749_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1523-1747.ep12371732","article-title":"Epidermis as a secretory tissue: an in vitro tissue model to study keratinocyte secretion","volume":"102","author":"Katz","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/1523-1747.ep12371721","article-title":"Epidermis as a secretory tissue","volume":"102","author":"Boyce","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0100","series-title":"Histopathology of the Skin","first-page":"156","article-title":"Non infectious erythematous, papular, and squamous diseases. Psoriasis","author":"Lever","year":"1990"},{"key":"10.1111\/1523-1747.ep12612749_bb0105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.160.4.1027","article-title":"Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes","volume":"160","author":"Briggaman","year":"1984","journal-title":"J Exp Med"},{"key":"10.1111\/1523-1747.ep12612749_bb0110","series-title":"Thesis","article-title":"Polymorphonuclear leukocytes and psoriasis","author":"Chang","year":"1989"},{"key":"10.1111\/1523-1747.ep12612749_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1523-1747.ep12505666","article-title":"Tissue plasminogen activator in psoriasis","volume":"95","author":"Jensen","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12612749_bb0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.bi.49.070180.003113","article-title":"Protein inhibitors of proteinases","volume":"49","author":"Laskowski","year":"1980","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/1523-1747.ep12612749_bb0130","first-page":"882","article-title":"Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies","volume":"133","author":"de Water","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/1523-1747.ep12612749_bb0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3476(86)80945-3","article-title":"Elastase-\u03b11 -proteinase inhibitor in early diagnosis of neonatal sepsis","volume":"108","author":"Speer","year":"1986","journal-title":"J Pediatr"},{"key":"10.1111\/1523-1747.ep12612749_bb0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(89)91142-2","article-title":"Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal","volume":"1","author":"Rocker","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12612749_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0140-6736(93)90558-X","article-title":"Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis","volume":"341","author":"Leff","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12612749_bb0150","first-page":"959","article-title":"ELISA for quantitative measurement of low-molecular-weight bronchial protease inhibitor in human sputum","volume":"129","author":"Kramps","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/1523-1747.ep12612749_bb0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1183\/09031936.93.02070623","article-title":"Local increase of antiproteinase and neutrophil elastase-\u03b1l-proteinase inhibitor complexes in lung cancer","volume":"2","author":"Marchandise","year":"1989","journal-title":"Eur Respir J"},{"key":"10.1111\/1523-1747.ep12612749_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0009-8981(90)90241-J","article-title":"Polymorphonuclear elastase in neonatal sepsis","volume":"193","author":"Tsaka","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1111\/1523-1747.ep12612749_bb0165","first-page":"218","article-title":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance","volume":"133","author":"Weiland","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/1523-1747.ep12612749_bb0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(197902)43:2<585::AID-CNCR2820430227>3.0.CO;2-0","article-title":"Tumor antigen of human cervical squamous cell carcinoma. Correlation of circulating levels with disease progress","volume":"43","author":"Kato","year":"1979","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12612749_bb0175","first-page":"661","article-title":"Tumor markers CA125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix","volume":"73","author":"Duk","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1111\/1523-1747.ep12612749_bb0180","first-page":"652","article-title":"Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA125, SCC antigen, and CEA levels in relation to clinical and histopathologic tumor characteristics","volume":"64","author":"Duk","year":"1989","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12612749_bb0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1346-8138.1993.tb01296.x","article-title":"Significance of elevated serum squamous cell carcinoma (SCC)-related antigen and lactate dehydrogenase (LDH) levels in senile erythroderma following eczema","volume":"20","author":"Tsukahara","year":"1993","journal-title":"J Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0190","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0190-9622(90)70088-Y","article-title":"Squamous cell carcinoma antigen in patients with cutaneous disorders","volume":"22","author":"Campbell","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12612749_bb0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00595492","article-title":"Human skin proteases. Partial purification and characterization of a protease inhibitor","volume":"243","author":"Fr\u00e4ki","year":"1972","journal-title":"Arch Derm Forsch"},{"key":"10.1111\/1523-1747.ep12612749_bb0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00417711","article-title":"The antiproteolytic compound \u03b12-macroglobulin in human skin","volume":"280","author":"Kramer","year":"1988","journal-title":"Arch Dermatol Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15420287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15420287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T21:24:09Z","timestamp":1705181049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15420287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["S0022202X15420287"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12612749","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}